Lallemand joins the Bureau of the Strategic Orientation Committee of the ‘Grand Défi Ferments du Futur’ and will be represented by four…
As a co-founding partner, Lallemand Health Solutions proudly presents the fourth edition of the Mind, Mood & Microbes International conference on Microbiome-Gut-Brain…
Lallemand Health Solutions will present its probiotic innovations at Vitafoods Europe in Geneva Palexpo, Switzerland, from May 9-11, 2023. Probiotic Breakthrough: Organic…
Apsen Farmaceutica, Lallemand Health Solutions’ commercial partner in Brazil, is publishing new positive results on the influence of Cerebiome® on the gut…
Sylvie Binda, Vice President Research and Development at Lallemand Health Solutions will contribute to the 6th edition of the Journée Microbiotes et…
Lallemand Health Solutions is launching the first and unique organic version of probiotic yeast Saccharomyces boulardii to mark the hundredth anniversary of…
Renowned scientists from around the world gathered in Montreal at the occasion of the 12th edition of Scientific Exchange event, organized by…
Lallemand is joining forces by getting involved in the steering committee of the Grand Défi Ferments du Futur[1], a highly strategic program…
Sylvie Binda, vice-president research and development at Lallemand Health Solutions has been elected as a new member of the board of directors…
Vincent Thomas, Ph.D., is joining Lallemand Health Solutions as R&D Innovation Director. Mr. Thomas will start his new position on December 5…
